The millennial - skew telehealth platform Hims & Hers announced Monday that is now offering client a compound version of semaglutide , the participating ingredient in democratic system of weights loss drugs like Ozempic and Wegovy .
Customers will be able-bodied to get a prescription for the drug from a accredited wellness concern supplier directly on the platform . A calendar month ’s supplying of theweight loss medicinal drug will get at $ 199 — one C of dollars cheaper thanOzempic ’s nearly $ 1,000 list priceand Wegovy’s$1,349 price tag .
The ship’s company ’s shares soaredover 30 % during Mondaytrading following the word .
The company is offering compounded semaglutide for $199 a month.Image: Hims & Hers
The declaration come as rocket demand for GLP-1 medicinal drug , the year of drugs that Ozempic , Wegovy and Eli Lilly ’s Zepbound belong to to , has made them harder to access . An Eli Lilly executive told Quartz that it will take aGLP-1 pillto speech current provision constraints .
When a medication is in shortage , the Food and Drug Administration ( FDA ) allow drug manufacturers to make compounded , or altered , version of the drug if they gather specific regulative demand . However , the government agency does not reexamine the safety and efficaciousness of these ware .
In January , the FDA said it had receivedadverse reportsfrom patients take a compounded semaglutide and recommended that affected role not use a compounded drug if an approved drug is available .
Hims & Hers was establish in 2017 , known as just “ Hims ” at the clip , as a chopine for men to get prescription online for cavernous disfunction and hair loss medicine . Since then , it has expanded to volunteer treatments for men and women to address skin care , anxiety , and overall intimate health .
In December , Hims & Herslaunched a weight exit broadcast that included access to non - GLP-1 weight deprivation medications . The company ’s other weighting loss medication offerings sharpen on treating the rudimentary causes of weightiness gain . In the company ’s first quarterly garner report of 2024 , it projected that its weight unit loss program will generate $ 100 million by the end of 2025 .
In Monday ’s announcement , Hims & Hers said that it also plan to volunteer branded GLP-1 drugs as supplies becomes more useable .
This clause in the beginning look onQuartz .
Eli LillyPeptide hormonesSemaglutide
Daily Newsletter
Get the best tech , science , and culture news in your inbox daily .
News from the future , delivered to your nowadays .
You May Also Like
